Literature DB >> 2184033

HIV-1 replication is controlled at the level of T cell activation and proviral integration.

M Stevenson1, T L Stanwick, M P Dempsey, C A Lamonica.   

Abstract

During progression of the Acquired Immune Deficiency Syndrome (AIDS), the human immunodeficiency virus type 1 (HIV-1) is harbored in CD4+ T cells, which act as the primary reservoir for the virus. In vitro, HIV-1 requires activated T cells for a productive infection; however, in vivo, the number of circulating T cells in the activated state that are potential targets for HIV-1 infection is low. We have investigated the ability of HIV-1 to infect resting T cells, and the consequences of such an infection. T cell activation was not required for HIV-1 infection; however, viral DNA was unable to integrate in resting T cells and was maintained extrachromosomally. Subsequent T cell activation allowed integration of extrachromosomal forms and led to a productive viral life cycle. Extrachromosomal forms of viral DNA were found to persist for several weeks after infection of resting T cells and, following T cell activation, these forms maintained their ability to integrate and act as a template for infectious virus. Several lines of evidence, including temporal analysis of HIV-1 replication and analysis of an HIV-1 integrase deletion mutant, indicated that extra-chromosomal HIV-1 DNA genomes were transcriptionally active. These results are compatible with a model whereby HIV-1 can persist in a non-productive extra-chromosomal state in resting T cells until subsequent antigen-induced or mitogen-induced T cell activation, virus integration and release. Thus agents that induce T cell activation may control the rate of HIV-1 replication and spread during AIDS progression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2184033      PMCID: PMC551849          DOI: 10.1002/j.1460-2075.1990.tb08274.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  50 in total

1.  Structure of the termini of DNA intermediates in the integration of retroviral DNA: dependence on IN function and terminal DNA sequence.

Authors:  M J Roth; P L Schwartzberg; S P Goff
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

2.  The palindromic LTR-LTR junction of Moloney murine leukemia virus is not an efficient substrate for proviral integration.

Authors:  L I Lobel; J E Murphy; S P Goff
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.

Authors:  S J Arrigo; S Weitsman; J D Rosenblatt; I S Chen
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

4.  Retrovirus vectors containing an internal attachment site: evidence that circles are not intermediates to murine retrovirus integration.

Authors:  J Ellis; A Bernstein
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

6.  Phasing of protein-induced DNA bends in a recombination complex.

Authors:  U K Snyder; J F Thompson; A Landy
Journal:  Nature       Date:  1989-09-21       Impact factor: 49.962

7.  Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals.

Authors:  M C Psallidopoulos; S M Schnittman; L M Thompson; M Baseler; A S Fauci; H C Lane; N P Salzman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Quantitation of mRNA by the polymerase chain reaction.

Authors:  A M Wang; M V Doyle; D F Mark
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Intramolecular integration within Moloney murine leukemia virus DNA.

Authors:  C Shoemaker; J Hoffman; S P Goff; D Baltimore
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

View more
  343 in total

1.  The Nef protein of HIV-1 associates with rafts and primes T cells for activation.

Authors:  J K Wang; E Kiyokawa; E Verdin; D Trono
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

2.  Antigen-driven CD4+ T cell and HIV-1 dynamics: residual viral replication under highly active antiretroviral therapy.

Authors:  N M Ferguson; F deWolf; A C Ghani; C Fraser; C A Donnelly; P Reiss; J M Lange; S A Danner; G P Garnett; J Goudsmit; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Expression of MHC class II in T cells is associated with increased HIV-1 expression.

Authors:  M Saifuddin; G T Spear; C Chang; K A Roebuck
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA.

Authors:  N Vandegraaff; R Kumar; C J Burrell; P Li
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation.

Authors:  Catia T Perciani; Bashir Farah; Rupert Kaul; Mario A Ostrowski; Salaheddin M Mahmud; Omu Anzala; Walter Jaoko; Kelly S MacDonald
Journal:  J Clin Invest       Date:  2019-01-22       Impact factor: 14.808

7.  Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1.

Authors:  T Pierson; T L Hoffman; J Blankson; D Finzi; K Chadwick; J B Margolick; C Buck; J D Siliciano; R W Doms; R F Siliciano
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

8.  Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription.

Authors:  P Dasgupta; P Saikumar; C D Reddy; E P Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 9.  HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors.

Authors:  Silke Wissing; Nicole L K Galloway; Warner C Greene
Journal:  Mol Aspects Med       Date:  2010-06-09

10.  Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.

Authors:  Theodore C Pierson; Yan Zhou; Tara L Kieffer; Christian T Ruff; Christopher Buck; Robert F Siliciano
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.